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protective before the establishment of intracellu-
lar replication. Therefore, successful elimination
of the pathogen depends mainly on efﬁcient
interactions between antigen-speciﬁc T-cells and
infected macrophages [12]. Signiﬁcantly higher
cell proliferation and interferon-c production has
been shown in patients who had recovered from
melioidosis, and this was an indication of the
development of a speciﬁc cell-mediated immune
response to B. pseudomallei [7]. The current study
demonstrated that exposure to B. pseudomallei
may lead to the formation of speciﬁc antibodies
and the development of CMI in healthy individ-
uals. An adequate cell-mediated immune
response to B. pseudomallei may prevent the
development of disease. Based on these obser-
vations, a more comprehensive study is warran-
ted since there may be signiﬁcant implications
for individuals exposed to B. pseudomallei who
may require immunosuppression or chemother-
apy.
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ABSTRACT
Total lymphocyte counts, CD4 T-lymphocyte
counts and CD4 ⁄CD8 ratios were measured in 30
anti-retroviral-naive HIV-seropositive patients
upon hospital admission for acute community-
acquired pneumonia (CAP) caused by Streptococ-
cus pneumoniae, and again 1 month after resolution
of infection. There was a signiﬁcant depression of
the total lymphocyte count (p < 0.005) and CD4 T-
lymphocyte count (p < 0.001) in the acute stage of
CAP caused by S. pneumoniae, with a subsequent
increase in 90% (27 ⁄ 30) of cases after resolution of
the infection. There was no signiﬁcant difference
in the CD4 ⁄CD8 T-lymphocyte ratio on admission
compared with 1 month later (p 0.9).
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Signiﬁcant depression of total lymphocyte and
CD4 T-lymphocyte subset counts may occur in
Corresponding author and reprint requests: G. Schleicher,
Division of Pulmonology, Department of Medicine, Johannes-
burg Hospital and University of the Witwatersrand, Johan-
nesburg, South Africa
E-mail: Schleicher@worldonline.co.za
Research Note 587
 2004 Copyright by the European Society of Clinical Microbiology and Infectious Diseases, CMI, 10, 574–592
both HIV-seropositive and HIV-seronegative
patients in response to stress, inﬂammation or
sepsis, or may be associated with idiopathic CD4
lymphopenia [1–3]. In HIV-seropositive patients,
CD4 T-lymphocyte depression has been docu-
mented in acute bacterial community-acquired
pneumonia (CAP), acute viral infections and
pulmonary tuberculosis [4,5]. These variations
result in changes in CD4 T-lymphocyte counts
that could lead to prognostic difﬁculties in HIV-
seropositive patients with acute CAP. This study
investigated the alterations in total lymphocyte
and CD4 T-lymphocyte counts in HIV-seroposit-
ive patients during the course of acute CAP
caused by Streptococcus pneumoniae.
A retrospective chart review was done for all
HIV-seropositive patients admitted to the Johan-
nesburg Hospital, Johannesburg, South Africa
between January 2001 and March 2003 with
S. pneumoniae CAP and documented total lym-
phocyte and T-cell subset counts upon admission
and after resolution of infection. Thirty patients
were identiﬁed and their hospital records studied.
The study was approved by the University of the
Witwatersrand Human Research Ethics Commit-
tee (Medical).
All patients were known to be HIV-seroposit-
ive, were ‡ 18 years of age, and were naive to anti-
retroviral therapy. A diagnosis of CAP caused by
S. pneumoniae was made if a patient had a new
inﬁltrate on the chest radiograph and three or
more clinical signs of pneumonia (fever, produc-
tive cough, pleuritic chest pain, tachypnoea or
hypoxaemia), plus either a positive blood culture
for S. pneumoniae (11 patients), a positive sputum
culture for S. pneumoniae (14 patients), or a
positive urinary antigen detection test (BINAX
NOW; Binax Inc., Portland, ME, USA) (ﬁve
patients). Patients were excluded if they had a
concomitant diagnosis of Pneumocystiis carinii
pneumonia or pulmonary tuberculosis, or if they
were not considered cured at the follow-up visit.
A total white cell count, a total lymphocyte
count and a T-lymphocyte subset count were
performed when the patients were admitted to
the hospital for CAP, and 1 month later at the
follow-up visit. Blood samples were collected in
EDTA tubes. White cell counts and differential
leucocyte counts were analysed by automated
Coulter counter (Coulter MAX-M; Beckman Coul-
ter, Fullerton, CA, USA). CD3, CD4 and CD8
T-lymphocyte subsets were determined by dual-
colour ﬂow cytometry, using monoclonal anti-
bodies CD45-FITC ⁄CD14-PE, CD3-FITC ⁄CD4-PE,
CD3-FITC ⁄CD8-PE, CD8-FITC ⁄CD38-PE, CD8-
FITC ⁄HLA-DR-PE (Simultest reagents; Becton
Dickinson, San Jose, CA, USA), and analysed on
a FACsort analyser by SimulSET software (Becton
Dickinson). The Wilcoxon matched-pairs test was
used to compare values during and after resolu-
tion of CAP. Results were reported as the median
and the interquartile range (IQR: 25–75% centile).
Thirty patients met the criteria and were inclu-
ded in the study. All patients were African; there
were 11 males and 19 females, and the median
age was 32 years.
The median CD4 T-lymphocyte count upon
admission was 112 · 106 cells ⁄L (IQR 54–212),
compared with 270 · 106 cells ⁄L (IQR 107–419)
1 month later (p 0.000009) (Fig. 1). The median
total lymphocyte count was 0.99 · 109 cells ⁄L
(IQR 0.6–1.8) upon admission, compared with
1.73 · 106 cells ⁄L (1.39–2.24) 1 month later
(p 0.0047) (Fig. 2). Of the total white cell counts,
there were 10.15% (4.65–13.7%) lymphocytes on
admission, compared with 40.25% (21.4–52.2%)
1 month later (p 0.0022). There was no signiﬁcant
difference in the CD4 ⁄CD8 T-lymphocyte ratio
upon admission compared with 1 month later
(p 0.9).
On admission, 27 (90%) of 30 patients had a
CD4 T-lymphocyte count of < 200 · 106 cells ⁄L,
compared with only 11 (37%) patients 1 month
later. Twenty-seven (90%) of the 30 patients had a
rise in the CD4 T-lymphocyte count at 1 month
compared with that upon admission.
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Wilcoxon matched pairs test (p 0. 000009)
Min Max 25% 75% Median
On admission 14.00 439.00 54.00 212.00 112.00
One month later 7.00 578.00 107.00 419.00 270.00
Fig. 1. CD4 T-lymphocyte counts (· 106 cells ⁄L) upon
admission and 1 month later.
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HIV infection leads to progressively lower
levels of circulating CD4 T-lymphocytes in per-
ipheral blood. Signiﬁcant decreases in the CD4
T-lymphocyte count have been noted in acute
viral infections with, for example, cytomegalovi-
rus and hepatitis B virus, as well as with
tuberculosis, certain bacterial infections, and
after major surgery or trauma. The transient
lymphopenia during the acute phase of illness is
probably associated with a redistribution of
leukocytes between the peripheral circulation
and the lymphoid organs and local body com-
partments, such as the lungs. High levels of
endogenous corticosteroids and inﬂammatory
cytokines, such as tumour necrosis factor alpha,
which are released during acute infection and
stress, are also associated with total lymphocyte
count and lymphocyte subset depression [6]. The
CD4 ⁄CD8 ratios are not changed signiﬁcantly.
This is caused by a simultaneous decrease in the
CD8 T-lymphocyte count during the acute epi-
sode of bacterial infection, as has been noted in
HIV-seronegative patients with bacterial sepsis
[3], and in a mixed HIV-seronegative and HIV-
seropositive population with pneumonia [4].
This acute depression in circulating CD4
T-lymphocytes has been shown to be reversible
in the case of bacterial infections in both HIV-
seropositive and HIV-seronegative patients [3,4].
In contrast, HIV-seropositive patients with tuber-
culosis may not experience a signiﬁcant increase
in the CD4 T-lymphocyte count after treatment
with anti-tuberculosis chemotherapy, especially if
they have advanced HIV infection with an initial
CD4 T-lymphocyte count of < 50 · 106 cells ⁄L [7,8].
To our knowledge, this is the ﬁrst study to
investigate speciﬁcally the effects of infection with
S. pneumoniae, the most common cause of CAP in
African HIV-seropositive patients, on CD4
T-lymphocyte counts. The results demonstrate
that the acute decrease in circulating total
lymphocytes and CD4 T-lymphocyte subsets is
reversible in most patients, regardless of the stage
of HIV infection and in the complete absence of
anti-retroviral therapy. The generalised lymp-
hopenia may lead to misclassiﬁcation of the stage
of HIV infection if evaluated during the acute
illness only [9], or may lead to worsening tran-
sient immunosuppression with temporary in-
creased susceptibility to opportunistic infections.
It was concluded that a CD4 T-lymphocyte count
measured during the acute stage of infection with
S. pneumoniae should not be used to determine the
stage of HIV disease or prognosticate on the
course of HIV infection.
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Min Max 25% 75% Median
On admission 0.15 2.29 0.60 1.80 0.99
One month later 0.82 3.16 1.39 2.24 1.73
Fig. 2. Total lymphocyte counts ( · 106 cells ⁄L) upon
admission with pneumonia (B) and 1 month later (A).
Research Note 589
 2004 Copyright by the European Society of Clinical Microbiology and Infectious Diseases, CMI, 10, 574–592
